Overview

Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma

Status:
RECRUITING

Trial end date:
2031-01-30

Target enrollment:

Participant gender:

Summary

This phase II randomized trial compares the efficacy and safety of Toripalimab combined with three different platinum-based induction chemotherapy regimens, sequentially followed by standard concurrent chemoradiotherapy, for the treatment of locally advanced nasopharyngeal carcinoma (NPC). The study is aimed to pick up the most effective platinum-based induction chemotherapy regimen plus Toripalimab for these patients which provides the most survival benefit.

Phase:

PHASE2

Details

Lead Sponsor:

Sun Yat-sen University

Treatments:

CCDC6 protein, human